Augmentation of antitumour activity of defucosylated chimeric anti-CCR4 monoclonal antibody in SCID mouse model of adult T-cell leukaemia/lymphoma using G-CSF

Br J Haematol. 2008 Mar;140(5):586-9. doi: 10.1111/j.1365-2141.2007.06947.x. Epub 2008 Jan 16.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Animals
  • Antibodies, Monoclonal / therapeutic use*
  • Antineoplastic Agents / therapeutic use
  • Disease Models, Animal
  • Granulocyte Colony-Stimulating Factor / therapeutic use
  • Humans
  • Leukemia-Lymphoma, Adult T-Cell / therapy*
  • Mice
  • Mice, SCID
  • Receptors, CCR4 / immunology*

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • CCR4 protein, human
  • Receptors, CCR4
  • Granulocyte Colony-Stimulating Factor
  • nartograstim